160 related articles for article (PubMed ID: 21054210)
21. Goitrous hypothyroidism due to iodide-trapping defect.
Saito K; Yamamoto K; Yoshida S; Manabe S; Suzuki M; Takai T; Saito T; Kuzuya T; Moriyama S
J Clin Endocrinol Metab; 1981 Dec; 53(6):1267-72. PubMed ID: 6271803
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
23. Silent but Not Harmless: A Synonymous
Geysels RC; Bernal Barquero CE; Martín M; Peyret V; Nocent M; Sobrero G; Muñoz L; Signorino M; Testa G; Castro RB; Masini-Repiso AM; Miras MB; Nicola JP
Front Endocrinol (Lausanne); 2022; 13():868891. PubMed ID: 35600585
[TBL] [Abstract][Full Text] [Related]
24. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.
Pohlenz J; Medeiros-Neto G; Gross JL; Silveiro SP; Knobel M; Refetoff S
Biochem Biophys Res Commun; 1997 Nov; 240(2):488-91. PubMed ID: 9388506
[TBL] [Abstract][Full Text] [Related]
25. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect.
Matsuda A; Kosugi S
J Clin Endocrinol Metab; 1997 Dec; 82(12):3966-71. PubMed ID: 9398697
[TBL] [Abstract][Full Text] [Related]
26. An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.
Bernal Barquero CE; Martín M; Geysels RC; Peyret V; Papendieck P; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2022 Jan; 32(1):19-27. PubMed ID: 34726525
[No Abstract] [Full Text] [Related]
27. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
28. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
29. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
[TBL] [Abstract][Full Text] [Related]
30. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
Josefsson M; Grunditz T; Ohlsson T; Ekblad E
Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
[TBL] [Abstract][Full Text] [Related]
31. Anion selectivity by the sodium iodide symporter.
Van Sande J; Massart C; Beauwens R; Schoutens A; Costagliola S; Dumont JE; Wolff J
Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351
[TBL] [Abstract][Full Text] [Related]
32. Complete iodide trapping defect in two cases with congenital hypothyroidism: adaptation of thyroid to huge iodide supplementation.
Leger FA; Doumith R; Courpotin C; Helal OB; Davous N; Aurengo A; Savoie JC
Eur J Clin Invest; 1987 Jun; 17(3):249-55. PubMed ID: 3040420
[TBL] [Abstract][Full Text] [Related]
33. Scintigraphic evaluation of primary congenital hypothyroidism: results of the Greek screening program.
Panoutsopoulos G; Mengreli C; Ilias I; Batsakis C; Christakopoulou I
Eur J Nucl Med; 2001 Apr; 28(4):529-33. PubMed ID: 11357505
[TBL] [Abstract][Full Text] [Related]
34. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
35. Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defect.
Fujiwara H; Tatsumi K; Miki K; Harada T; Okada S; Nose O; Kodama S; Amino N
J Clin Endocrinol Metab; 1998 Aug; 83(8):2940-3. PubMed ID: 9709973
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures.
Kosugi S; Sato Y; Matsuda A; Ohyama Y; Fujieda K; Inomata H; Kameya T; Isozaki O; Jhiang SM
J Clin Endocrinol Metab; 1998 Nov; 83(11):4123-9. PubMed ID: 9814502
[TBL] [Abstract][Full Text] [Related]
37. A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect.
Fujiwara H; Tatsumi K; Tanaka S; Kimura M; Nose O; Amino N
Thyroid; 2000 Jun; 10(6):471-4. PubMed ID: 10907989
[TBL] [Abstract][Full Text] [Related]
38. Comparison of radioisotopic and ultrasonic scanning in the evaluation of neonatal hypothyroidism.
Niu DM; Chao T; Tiu CM; Chou YH; Chu YK; Hwang B
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):345-50. PubMed ID: 8605650
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
40. Switching from MAPK-dependent to MAPK-independent repression of the sodium-iodide symporter in 2D and 3D cultured normal thyroid cells.
Ingeson-Carlsson C; Nilsson M
Mol Cell Endocrinol; 2013 Dec; 381(1-2):241-54. PubMed ID: 23969277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
